The Readout Loud
Episode 25: A genome-editing first, Trump on Wall Street, and biotech red flags
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Can genome-editing work in actual people? Are CEOs oversharing? And how do you sniff out a bad bet before it happens?